Utilizing Engineered E. Coli as an Asymmetric Reducing Biocatalyst Towards Serotonin Reuptake Inhibitors

Richard J. Hammond, Benjamin W. Poston, Brent D. Feske

Research output: Contribution to conferencePresentation

Abstract

This presentation was given at the ACS National Meeting.

Original languageAmerican English
StatePublished - Jan 1 2007
EventACS National Meeting -
Duration: Jan 1 2007 → …

Conference

ConferenceACS National Meeting
Period01/1/07 → …

Keywords

  • Asymmetric reducing biocatalyst
  • Engineered E. Coli
  • Serotonin reuptake inhibitors
  • Utilizing

DC Disciplines

  • Chemistry

Fingerprint

Dive into the research topics of 'Utilizing Engineered E. Coli as an Asymmetric Reducing Biocatalyst Towards Serotonin Reuptake Inhibitors'. Together they form a unique fingerprint.

Cite this